Evidence map›Paper›PMID 25125210›Full record

ArticleRetrovirology2014

Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.

Teresa H Evering, Edwin Kamau, Leslie St Bernard, Charles B Farmer, Xiang-Peng Kong, Martin Markowitz

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Next-generation sequencing of HIV-1 single genome amplicons.Biomolecular detection and quantification · 2019
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Envelope gene evolution and HIV-1 neuropathogenesis.Journal of neuroinfectious diseases · 2015
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Teresa H EveringAaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, USA. tevering@adarc.org.
Edwin Kamau
Leslie St Bernard
Charles B Farmer
Xiang-Peng Kong
Martin Markowitz
Aaron Diamond AIDS Research Center · USNew York University · USRockefeller University · US

Funding

Vaccines to Induce Functional Antibodies Targeting the V2 Loop P01AI100151 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KONG, XIANGPENG, ZOLLA-PAZNER, SUSAN B · 2012 to 2017
$15.4M
The Role of HIV-1 Evolution in NeuroadaptationK08MH090900 · NIMH · AARON DIAMOND AIDS RESEARCH CENTER · PI EVERING, TERESA · 2010 to 2014
$950k
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH /CHARTER/ -278022005-278022005N01MH022005 · NIMH · UNIVERSITY OF CA -SAN DIEGO · PI GRANT, IGOR · 2003 to 2006
–
NIAID NIH HHS AI100151NIAID NIH HHS P01 AI100151NIMH NIH HHS K08 MH090900NIMH NIH HHS K08MH090900NIMH NIH HHS N01 MH022005
6 · The paper itself

Abstract

backgroundThe widespread use of highly effective, combination antiretroviral therapy (cART) has led to a significant reduction in the incidence of HIV-associated dementia (HAD). Despite these advances, the prevalence of HIV-1 associated neurocognitive disorders (HANDs) has been estimated at approximately 40%-50%. In the cART era, the majority of this disease burden is represented by asymptomatic neurocognitive impairment and mild neurocognitive disorder (ANI and MND respectively). Although less severe than HAD, these diagnoses carry with them substantial morbidity.

resultsIn this cross-sectional study, single genome amplification (SGA) was used to sequence 717 full-length HIV-1 envelope (env) clade B variants from the paired cerebrospinal fluid (CSF) and blood plasma samples of fifteen chronically infected HIV-positive individuals with normal neurocognitive performance (NCN), ANI and MND. Various degrees of compartmentalization were found across disease states and history of cART utilization. In individuals with compartmentalized virus, mean HIV-1 env population diversity was lower in the CSF than plasma-derived variants. Overall, mean V1V2 loop length was shorter in CSF-derived quasispecies when compared to contemporaneous plasma populations, and this was found to correlate with a lower mean number of N-linked glycosylation sites in this region. A number of discrete amino acid positions that correlate strongly with compartmentalization in the CSF were identified in both variable and constant regions of gp120 as well as in gp41. Correlated mutation analyses further identified that a subset of amino acid residues in these compartmentalization "hot spot" positions were strongly correlated with one another, suggesting they may play an important, definable role in the adaptation of viral variants to the CSF. Analysis of these hot spots in the context of a well-supported crystal structure of HIV-1 gp120 suggests mechanisms through which amino acid differences at the identified residues might contribute to viral compartmentalization in the CSF.

conclusionsThe detailed analyses of SGA-derived full length HIV-1 env from subjects with both normal neurocognitive performance and the most common HAND diagnoses in the cART era allow us to identify novel and confirm previously described HIV-1 env genetic determinants of neuroadaptation and relate potential motifs to HIV-1 env structure and function.

Indexed as

AdultCognition DisordersCross-Sectional StudiesFemaleGlycosylationHIV-1HIV Envelope Protein gp120HIV InfectionsHumansMaleMiddle AgedHIV Envelope Protein gp120

Identifiers

PMID25125210
PMCPMC4145222
OpenAlexW2161198612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.